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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Ipomoea batatas,  Agaricus blazei and Smallanthus sonchifolius
are known to favorably influence diabetes mellitus. To clarify
their antidiabetic efficacy and hypoglycemic mechanisms, we
treated streptozotocin induced diabetic rats with daily oral
feeding of powdered Ipomoea batatas (5 g kg−1 d −1),  Agaricus
blazei (1 g kg−1 d−1) or Smallanthus sonchifolius (4 g kg−1 d−1) for 2
months. Treatments with Ipomoea batatas or Agaricus blazei,
but not Smallanthus sonchifolius, significantly suppressed the
increases of fasting plasma glucose and hemoglobin A1c levels,
and restored body weight loss during diabetes. Serum insulin
levels after oral glucose administration tests increased along the
treatments of Ipomoea batatas or Agaricus blazei. Moreover,
Ipomoea batatas and Agaricus blazei reduced superoxide produc 
tion from leukocytes and vascular homogenates, serum 8 oxo 2' 
deoxyguanosine, and vascular nitrotyrosine formation of diabetic
rats to comparable levels of normal control animals. Stress 
and inflammation related p38 mitogen activated protein kinase
activity and tumor necrosis factor α production of diabetic rats
were significantly depressed by Ipomoea batatas administration.
Histological examination also exhibited improvement of pancreatic
β cells mass after treatments with Ipomoea batatas or Agaricus
blazei. These results suggest that hypoglycemic effects of Ipomoea
batatas or Agaricus blazei result from their suppression of oxida 
tive stress and proinflammatory cytokine production followed by
improvement of pancreatic β cells mass.
Key Words: hypoglycemic effect, oxidative stress, 
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Introduction Nowadays, diabetes mellitus in the industrialized countries
has spread to younger generation and the number of patients
is prospected to increase to 300 million or more worldwide by
the year 2025. Diabetes mellitus is a serious complex chronic
condition that is a major source of ill health worldwide. Even
optimal control of blood glucose can not prevent clinical diabetic
complications, so that diabetes therapy has revolved around
dietary measures including the use of traditional antihyperglycemic
medicines. Moreover, insulin or oral hypoglycemic drugs have
serious side effects on overdose medication. Therefore, there is a
real need today for further pharmacological study on the effective-
ness and side effects caused by the alternative medicines.
In fact, about 800 species of plants and mushrooms have been
reported to improve the metabolism of carbohydrates and to be
effective against diabetes mellitus.(1–3) However, only a few com-
pounds of antihyperglycemic plants and mushrooms have shown
the efficacy on the management of diabetes in randomized
trials.(3,4) Their hypoglycemic mechanisms in chronic treatment
are not clear and scientific evidences are very poor. In the present
study, we selected the three of plants and mushroom based on
the previous reports, Ipomoea batatas L. (Convolvulaceae), i.e.,
Caiapo, Agaricus blazei Murill (Agaricaceae), i.e., Agaricus, and
Smallanthus sonchifolius Poepp. & Endl. (Compositae), i.e.,
Yacon, which may improve on the balance of glucose and insulin
through a safe and effective program.
Ipomoea batatas is a white-skinned sweet potato originating
in Amazonis Brazil, and it has been used in Shikoku region of
Japan, as a folk medicine for the treatments of diabetes and other
metabolic diseases.(5,6) In concerning diet therapy of Ipomoea
batatas, the treatment for 3 months has been reported to lower the
plasma glucose and cholesterol levels in patients with type 2
diabetes.(7,8) Oral administration of Ipomoea batatas to diabetic
animal models for longer than 6 weeks was shown to prevent
and improve the symptoms of diabetes and hypoglycemia in
streptozotocin (STZ)-induced diabetic and obese Zucker rats.(9,10)
Further,  Ipomoea batatas has abundant phenolic compounds,
such as caffeic acid and its derivatives,(11) whose efficacious func-
tions(12) are expected to prove a number of health benefits.
Agaricus blazei is a medical mushroom that grows in North
America and Brazil, and it is widely taken, and described in the
world.(13) There are many reports on the immunological beneficial
properties such as anti-tumor,(14,15) anti-viral,(16) and disinfectant(17)
activities. Moreover, it is recently reported that β-glucan extracts
from Agaricus blazei could reduce blood glucose, triglyceride,
and cholesterol levels(18) as well as insulin-like action.(19)
Smallanthus sonchifolius roots are a rich source of fracto-
oligosacharides and have a long use tradition as food in the
Andean region. Expansion to other counties including New
Zealand, Japan and Brazil has been stimulated further by pre-
sumed medical properties of both roots and leaves.(20) The water-
soluble extract of its leaves has been recognized to have hypo-
glycemic effect,(21,22) antioxidant property,(23) and enhancement of
liver metabolism.(24) Natural and neutraceutical products including
the above three materials are highly expected on diabetes control.
In the present study, Ipomoea batatas,  Agaricus blazei, or
Smallanthus sonchifolius were fed with diet for 2 months to STZ-
induced type 2 diabetes rats, and their efficacy against diabetes
and diabetes-associated pathophysiologic changes including
pancreatic β-cells, insulin secretion, oxidative stress, and inflam-
matory cytokine production were investigated.
Materials and Methods
Preparation of experimental materials. Ipomoea batatas
(Caiapo) was grown in Kagawa Prefecture (Japan). Whole extract
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was obtained including the peel, because Ipomoea batatas
contains more phenolic compounds in the outer part than in the
center,(25) and then lyophilized to prepare a uniform powder.(26) The
powder was purchased from Fuji Sangyo Co., Ltd. (Kagawa,
Japan). All ingredients were measured by Japan Food Research
Laboratories (Tokyo, Japan) using the standard protocols recom-
mended by the Resources Council, the Science and Technology
Agency of Japan. The main composition was as follows: protein,
5.2%; carbohydrate, 78.3%; fiber, 11.0%. Ipomoea batatas had
also abundant phenolic compounds such as chlorogenic acid,
caffeic acid and its derivatives,(27) and high levels of vitamins
including ascorbic acid and tochopherol. It contained many
minerals including zinc, copper, manganese and selenium.
Agarics blazei (Agarics) fruit body was cultivated outdoors in
Brazil. Fruit bodies were air dried by ventilator with a blowing
temperature low than 60°C to maintain their enzyme activities,
powdered, and imported by Toei Pharmaceutical Co., Ltd. (Tokyo,
Japan). The main composition was as follows: protein, 38.5%;
carbohydrate, 27.7%; fiber, 20.6%; β-glucan, 12.4%. It had
also enzymes such as polyphenol oxidase, peroxidase, glucanase,
and laccase. It contained many minerals including large amounts
of zinc and copper, and certain amounts of manganese and
selenium.(28–30)
Smallanthus sonchifolius (Yacon) plants were grown in Brazil.
The tuberous roots and stems of Smallanthus sonchifolius were
peeled, sliced and dried at 40°C in a forced air circulation oven.
Partially dried slices were subjected to 60°C for 2 h to stop rapid
degradation of fructooligosaccharides,(31) milled, and imported
by Toei Pharmaceutical Co., Ltd. The main composition was as
follows: protein, 9.6%; carbohydrate, 66.0%; fiber, 11.6%. The
major proportion of carbohydrates was in the form of inulin-type
oligofructans and β-fructooligosaccharides.(20) The tubers had
chlorogenic acid and caffeic acid derivatives.(32,33) It also contained
ascorbic acid, and many minerals including zinc, copper, manga-
nese and selenium.
All diets for animals were prepared by mixing powdered test
materials and powdered standard diet (SP; Funabashi Farm,
Funabashi, Japan). The doses of Ipomoea batatas, Agarics blazei,
or Smallanthus sonchifolius were kept at 5 g/kg of body weight/
day, 1 g/kg of body weight/day, or 4 g/kg of body weight/day,
respectively. This is a dose likely to be in the upper limit of what
can be tolerated in long-term experiments in human as indicated
by the manufacturers.
Animals. Male Wistar rats weighing 130 g to 150 g (6 weeks
of age, Japan SLC, Inc., Shizuoka, Japan) were housed in an air-
conditioned room at 22 ± 2°C with 60 ± 5% humidity, under 12 h
light-dark cycle in the center for animal experiments of Kinki
University School of Medicine. Rats were given laboratory diets
as mentioned above and water ad labium. Rats were treated
according to the ethical guideline of Kinki University School of
Medicine Animal Committee.
Experimental procedure and sample collection. After
initial determination of fasting blood glucose levels at 7 weeks of
age, rats were intravenously injected the streptozotocin fluid
(STZ, Sigma Chemical Co., St. Louis, MO) at the dose of 45 mg/
kg (freshly dissolved in 3 mM citrate buffer pH 4.5). Blood
glucose levels were monitored on the fifth day after STZ injection
and thereafter at a fasting period of 18 h prior to the monitoring
once a week. Animals showing above 250 mg/dl of blood glucose
levels on the fifth day after STZ injection were selected as diabetic
rats for this study and randomly divided into 4 groups: (i) normal
diet (n = 5), (ii) Ipomoea batatas diet (n = 5), (iii) Agarics blazei
diet (n = 5), (iv) Smallanthus sonchifolius diet (n = 5). The treat-
ments with Ipomoea batatas,  Agarics blazei or Smallanthus
sonchifolius were performed for 8 weeks during 8 to 15 weeks
of age. For normal reference, non-diabetes control (n =5 )  w a s
also examined.
Body weight of normal and diabetic rats was weekly recorded
in fasting state. Food and water intake, and urine output for 24 h
were measured every other week (1, 3, 5, and 7th week after
treatments) individually in metabolic cages. Blood samples
were collected from the tail vein. Urine and serum samples were
stored at −80°C until the assay. Animals were sacrificed under
pentobarbital anesthesia in the eighth week after treatments,
and the pancreas, kidney and aorta were collected for the patho-
physiological examination.
Plasma glucose and HbA1c. Plasma glucose values were
obtained by the electric tip using glucose oxidase method(34)
(MediSense Xtra; Abbott Laboratories Inc., Tokyo, Japan). Levels
of glycosylated hemoglobin A1c (HbA1c) and total hemoglobin(35)
after 7 weeks of treatments were determined according to manu-
facture’s instruction (Liquitech HbA1cII; Roche Diagnostic
Systems, Branchburg, MO).
Serum insulin. Serum insulin levels 20 min after oral admin-
istration of 20% glucose solution were determined by radio-
immunoassay(36) using Rat Insulin radioimmunoassay (RIA) kit
(Linco Research Inc., St. Charles, MO) 1, 3, 5 and 7 weeks after
treatments. Fasting insulin levels were also measured in rats fasted
overnight in the eighth week after treatments using Ultrasensitive
Rat Insulin enzyme-linked immunosorbent assay (ELISA) kit
(Mercodia, Uppsala, Sweden).
Superoxide production by peripheral leukocytes. Super-
oxide production by polymorphonuclear leukocytes (PMNs) and
monocytes (MNCs) was measured using a gated flow cytometry
according to the methods described by Perticarari et al.(37) with
some modifications. Seven weeks after treatments fresh blood
was collected and erythrocytes were removed by Tris-bufferd
ammonium chloride lysis. White blood cells were preincubated
for 15 min in a shaking water bath in 37°C with 500 ng/ml
hydroethidium (HE) (Invitrogen Life Technologies, Carlsbad,
CA) in Hank’s Balanced Salt Solution containing 1% bovine
serum albumin (Sigma Chemical Co.), and then the reaction was
immediately stopped on ice. HE, a nonfluorescent compound
which can diffuse through cell membrane, is rapidly oxidized to
ethidium bromide by oxidative products, giving red fluorescence
emission. Superoxide levels produced by PMNs and MNCs were
evaluated by mean fluorescence intensity. Superoxide levels in
stimulated leukocytes in the presence of 1 μg/ml phorbol mirystate
acetate (PMA; Sigma-Aldrich Co.) were also measured.
Lucigenin enhanced chemiluminescence detection of
vascular superoxide. Vascular superoxide production was
measured using lucigenin (bis-N-methyl acridinium; Sigma-
Aldrich Co.)-enhanced chemiluminescence as described by
Guzik et al.(38) Chemiluminescence in the vascular homogenates
8 weeks after treatments was measured in Krebs-HEPES (N-2-
hydroxyethylpiperazine-N-2-ethanesulphonic acid) buffer con-
taining lucigenin (100 μM) using luminometer analyzer (PICO-
LITE 6100; Packard Instrument Co. Inc., Downers Grove, IL).
Specificity for superoxide was determined by coincubation with
tiron (20 mM) (4,5-dihydroxy-1,3-benzene disulfonic acid; Sigma-
Aldrich Co.). Superoxide production was expressed as chemilumi-
nescence counts/10 min/30 mg vessel wet weight.
Serum 8 oxo 2' deoxyguanosine (8 OHdG). Serum sam-
ples of 8 weeks after treatments of the experimental diets were
filtrated to remove high molecular weight products above 10,000
MW (Ultrafree-MC; Millipore Co., Bedford, MA). Thereafter, 8-
OHdG levels of the samples were determined(39) by high sensitive
commercial ELISA kit (Japan Institute for The Control of Aging,
Nikken SEIL Co., Shizuoka, Japan).
Urinary Tumor necrosis factor α (TNF α). Urine samples
of 5 and 7 weeks after treatments of the experimental diets were
centrifuged at 5,000 × g for 10 min. TNF-α level in the superna-
tants was measured(40) by BD Opt EIA Rat TNF ELISA kit II (BD
biosciences, San Jose, CA).
Western blot analysis. Protein from aortas were extracted
in a lysis buffer containing 0.1% sodium dodecylsulfate (SDS),doi: 10.3164/jcbn.10 78
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2% Triton X-100, 1% dithiothreitol and 9 M urea (Wako Pure
Chemical Industries, LTD., Osaka, Japan). For extraction from
tissues, aortas were excised and snap-frozen in liquid nitrogen
before homogenization in lysis buffer. Equal amounts of protein
(30 μg) were separated by SDS-polyacrylamide gel. Anti-
nitrotyrosine (Upstate biotechnology, Lake Placid, NY),(41) anti-
p38 mitogen-activated protein (MAP) kinase, and anti-phospho
p38 MAP kinase (Cell Signaling Technology, Danvers, MA)(42)
antibodies were used for western blot analysis. Bands were
visualized by enhanced chemiluminescence (Amersham Bio-
sciences, Buckinghamshire, UK) and were quantified by using
luminescent image analyzer (LAS-1000, Fuji Photo Film Co.,
LTD, Tokyo, Japan) and Image Gauge software version 3.12
(Fuji Photo Film). All antibodies were used as indicated by the
manufacturers.
Histochemical analysis of pancreatic β cells. Whole pan-
creatic tissues were fixed in 15% formalin neutral buffer solution
and embedded in paraffin. Sections were stained by hematoxylin
and eosin, and aldehyde fuchsin(43) for pancreatic β-cells popula-
tion. To quantify the contents of pancreatic β-cells, the 12 randomly
selected sections with the maximal lesion in each animal were
chosen. A computer-assisted morphometric analysis was per-
formed with a semiautomatic image computer system (Lumina
Vision version 1.5; Mitani Co., Maruoka, Japan) and software
for image analysis (Mac SCOPE version 2.5; Mitani Co.). The
numbers of islets per field were manually counted.
Statistical analysis. Values were expressed as mean ±
standard error of the mean (SEM). Data were analyzed by one-
way analysis of variance (ANOVA), followed by post hoc Scheffé
test. Differences were considered statistically significant at p<0.05.
Results
Body weight. Body weight significantly lowered in all the
diabetic groups compared with normal control (NC) group
(p<0.05, all diabetic groups vs NC) (Fig. 1). Two weeks after
treatments with the experimental diets, the body weight of
Ipomoea batatas-treated diabetic (Caiapo) and Agarics blazei-
treated diabetic (Agarics) groups was significantly increased
compared with that of untreated diabetic control (DC) group. The
weight of Caiapo group was 221.5 ± 11.2 g and that of Agaricus
group was 208.8 ± 16.6 g (p<0.05, Caiapo or Agarics group vs
DC 142.5 ± 6.1 g) 7 weeks after treatments. On the other hand,
Smallanthus sonchifolius-treated diabetic (Yacon) rats showed no
significant restoration of the body weight.
NC showed greater daily food intake than those of all the
diabetic groups for 3 weeks after the start of treatments, and
thereafter there were no significant differences observed among
any groups (data not shown). There were also no significant
differences in food intakes among DC, Caiapo, Agaricus and
Yacon groups during the experimental period.
Plasma glucose and HbA1c levels. Fasting blood glucose
levels of NC ranged from 82.5 ± 9.4 mg/dl to 111.2 ± 2.6 mg/dl
during the experiment. On the other hand, blood glucose levels of
DC were increased after injection of STZ, and 5 weeks later those
reached to the peak level (474.2 ± 34.1 mg/dl). In comparison
with DC, Caiapo and Agaricus groups showed significant
suppression on blood glucose levels after 3 weeks of treatments
(p<0.05, Caiapo or Agarics group vs DC). In contrast, Yacon
showed no significant hypoglycemic effect during the experimental
period (Fig. 2).
There was a significant increase in the level of glycosylated
HbA1c in DC after 7 weeks of STZ injection compared with
that of NC (p<0.01). Of note, the value of Caiapo group was
suppressed to 4.1 ± 0.2%, which was approximately the same
level as NC (p<0.01 vs DC, 7.6 ± 0.8%). Suppressive tendency was
also observed in Agaricus group (5.8 ± 0.7%). In contrast, HbA1c
level of Yacon group did not differ from that of DC (Fig. 3).
Furthermore, urinary ketone levels were increased in all of the
diabetic groups compared with NC after 5 weeks of STZ injection.
The levels were suppressed in Caiapo and Agaricus groups
compared with DC. On the other hand, Yacon had no effect on
urinary ketone (data not shown).
Fig. 1. Effects of treatments with Ipomoea batatas (Caiapo), Agaricus
blazei (Agarics) or Smallanthus sonchifolius (Yacon) on body weight
in STZ induced diabetic rats. Streptozotocin induced diabetic rats
were treated with daily oral feeding of powdered Ipomoea batatas
(5 g/kg body weight/day), Agaricus blazei (1 g/kg body weight/day) or
Smallanthus sonchifolius (4 g/kg body weight/day) for 2 months. Treat 
ments with Caiapo or Agaricus significantly restored weight loss during
diabetes, but Yacon had no effect on body weight loss. Normal control
(filled diamond), untreated diabetic control (filled square), Ipomoea
batatas (Caiapo) treated diabetic (filled triangle), Agaricus blazei
(Agarics) treated diabetic (open circle), and Smallanthus sonchifolius
(Yacon) treated diabetic (open triangle) rats. Values are mean ± SEM
(n = 5). *p<0.05 vs untreated diabetic control.
Fig. 2. Effects of treatments with Ipomoea batatas (Caiapo), Agaricus
blazei (Agarics) or Smallanthus sonchifolius (Yacon) on fasting blood
glucose levels in STZ induced diabetic rats. Blood glucose levels were
monitored on the fifth day after STZ injection and thereafter at a fast 
ing period of 18 h prior to the monitoring once a week. Hyperglycemia
was significantly suppressed by the treatments with Caiapo or Agarics,
but not with Yacon. Normal control (filled diamond), untreated diabetic
control (filled square), Ipomoea batatas (Caiapo) treated diabetic (filled
triangle), Agaricus blazei (Agarics) treated diabetic (open circle), and
Smallanthus sonchifolius (Yacon) treated diabetic (open triangle) rats.
Values are mean ± SEM (n =5 ) .  * p<0.05 vs untreated diabetic control. J. Clin. Biochem. Nutr. | May 2011 | vol. 48 | no. 3 | 197
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Serum insulin levels after glucose loading. Changes of
serum insulin levels 20 min after 400 mg/rat glucose loading were
shown in Fig. 4. In the first week of experiment, mean serum
insulin levels in all of the diabetic groups were remarkably
decreased to 0.74 ng/ml (p<0.01 vs NC, 2.3 ± 0.4 ng/ml). After 5
weeks of treatments with the experimental diets, the increases in
insulin levels were observed in Caiapo and Agaricus groups after
glucose loading. The levels of Caiapo groups was significantly
higher compared with DC (p<0.05). In the seventh week after
treatment, the mean value of Caiapo group was 2.7 ng/ml, and
thus recovered to the level comparable to that of NC, although
the error range was great (p<0.05 vs DC). By contrast, the levels
of serum insulin in Yacon group did not differ from those of
DC during the experiment. On the other hand, fasting insulin
levels remained unchanged in all the diabetic groups.
Oxidative stress. One major mechanism underlying STZ
toxicity is cytokine-mediated β-cell destruction in which oxidative
stress plays a key role.(44) First, we examined the changes of
superoxide production from leukocytes in normal or diabetic rats
with or without the treatments of Caiapo, Agarics, or Yacon for 8
weeks. Mean fluorescence intensity, which is equivalent to the
ability of superoxide production by a single monocyte or neutro-
phil, under phorbol mirystate acetate stimulation (1 μg/ml)
showed in DC group 1.6 times as high as that of NC groups 7
weeks after experiment (arbitrary units, mean fluorescence
intensity; DC 773.1 vs NC 474.8). Of note, mean intensity of
Caiapo group was suppressed by 495.7, approximately the same
level as the NC. Agarics or Yacon treatment did not significantly
influence on superoxide production from blood cells (arbitrary
units, mean fluorescence intensity; Agarics 634.9, Yacon 801.6).
There were also no differences in superoxide production without
stimulation between the groups.
Next, the levels of 8-OHdG, an additional oxidative stress
maker, were measured in the serum from normal or diabetic rats.
Level of serum 8-OHdG was 240.8 ± 58.3 pg/ml in untreated DC.
Only Yacon-treated rats showed significant increase of 8-OHdG
and the value was 104.0 ± 40 pg/ml 8 weeks after treatments.
In contrast, 8-OHdGs of Caiapo and Agaricus groups were
suppressed below the detectable limit (0.1 ng/ml).
Finally, in order to investigate the effects on oxidative stress
in the tissue under high blood glucose, lucigenin-enhanced
chemiluminescence was measured in aortas of diabetic rats of
the eighth week after treatments with Caiapo, Agarics, or Yacon.
Fluorescence level in aortas of DC was approximately 2.5 times
as high as that of NC, showing a significant increase in superoxide
production (p<0.05, DC 13,376.8 ± 1,994.9 counts vs NC
5,186.3 ± 715.8 counts). Caiapo group significantly reduced the
levels of superoxide production of tissue (5,985.3 ± 1,162.5
counts,  p<0.05 vs DC) (Fig. 5a). In addition, formation of
nitrotyrosine, another oxidative stress marker, was assessed in
aortas by western blotting. Nitrotyrosine formation was also
accompanied with the development of diabetes. Treatment of
Caiapo for 8 weeks significantly attenuated the formation (p<0.05,
Fig. 5b).
Urinary TNF α. Urinary TNF-α level 5 and 7 weeks after
treatments was illustrated in Fig. 6. In the fifth week of treatment,
urinary TNF-α level of the diabetic rats was increased by 6 to 9
times as high as that of NC (p<0.01, NC 23.6 ± 6.3 pg/ml vs DC
180.4 ± 11.2 pg/ml). The levels of Caiapo (141.1 ± 10.6 pg/ml)
and Agarics (150.9 ± 6.2 pg/ml) groups were significantly less
than that of DC (p<0.05 vs DC). In contrast, Yacon group
remained unchanged. In the seventh week, TNF-α levels showed
similar tendencies with those of the fifth week, although signifi-
cant differences between the groups were not observed. We also
measured the levels of serum TNF-α in the experimental groups.
The values were low (range of the mean from 9 pg/ml to 13 pg/ml)
and were not significantly different between the groups.
Mean urinary albumin was increased to 4.02 mg/day urine
albumin excretion (UAE) in DC group 5 weeks after the experi-
ment. Caiapo, Agaricus or Yacon reduced UAE to the level
comparable to that of NC group (1.5 mg/day mean UAE) (data
not shown).
After 1 week of the experiment, water intakes in all of the
diabetic rat groups were increased by 3-fold as much as that of
NC, and their urine excretions were also increased by 5-fold,
with no difference between DC and the other treated diabetic
groups. In addition, the ratio of kidney/body weight 8 weeks after
treatments became approximately twice in the diabetic rat groups
Fig. 3. Levels of HbA1c in STZ induced diabetic rats treated with
Ipomoea batatas (Caiapo), Agaricus blazei (Agarics) or Smallanthus
sonchifolius (Yacon) in the seventh week after treatments. HbA1c
values were reduced with treatment with Caiapo. Values are
mean ± SEM (n =5 ) .   ##p<0.01 vs normal control, **p<0.01 vs untreated
diabetic control. NC; normal control, D + None; untreated diabetic
control, D + Caiapo; Ipomoea batatas treated diabetic group,
D + Agarics;  Agaricus blazei treated diabetic group, D + Yacon;
Smallanthus sonchifolius treated diabetic group.
Fig. 4. Serum insulin levels after oral glucose administration in
Ipomoea batatas treated diabetic (Caiapo), Agaricus blazei treated
diabetic (Agarics) or Smallanthus sonchifolius treated diabetic (Yacon)
rats. The levels were determined 20 min after oral administration of
20% glucose solution by radioimmunoassay. Treatment with Caiapo for
2 months restored to serum insulin level comparable to that of normal
control. Normal control (filled diamond), untreated diabetic control
(filled square), Caiapo treated diabetic (filled triangle), Agaricus treat 
ed diabetic (open circle), and Yacon treated diabetic (open triangle)
rats. Values are mean ± SEM (n = 5). ##p<0.01 vs normal control, *p<0.05
vs untreated diabetic control.doi: 10.3164/jcbn.10 78
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compared with that of the NC, with no difference between DC
and the other treated diabetic groups (data not shown).
Activation of p38 mitogen activaed protein kinase.
Data of the superoxide production and TNF-α level in STZ-
induced diabetes rats suggest that Caiapo or Agaricus is capable
of depressing the increases in oxidative stress and inflammatory
responses. We examined p38 MAP kinase activation by western
blotting. P38 MAP kinase is potently and preferentially activated
by a variety of stress including oxidative stress and inflammatory
cytokines and receptor systems of the TNF family.(45)
Increases in p38 MAP kinase expression and its phosphoryla-
tion level were noted in aortas of diabetic rats compared with
normal rats (p<0.05, DC vs NC). Caiapo significantly decreased
these levels (p<0.05 vs DC), but Agaricus and Yacon were not
effective (Fig. 7a–c).
Pancreatic β cells. Representative light micrographs of pan-
creatic β-cells in NC, Agarics-treated, and DC rats were shown in
Fig. 8. Area and numbers of islet of Langerhans were recorded as
an index of pancreatic β-cells mass (Table 1). STZ treatment
caused a remarkable degranulation of pancreatic β-cells. In the
DC, the β-cells area for an islet and number of islets in pancreas
were decreased by 1/6 and 1/4, respectively, as compared with
those of NC (p<0.01, DC vs NC). Eight weeks after treatments, the
β-cells mass in Caiapo and Agarics groups were increased by
twice volume and more as compared with that of DC (p<0.05,
Caiapo or Agarics group vs DC). Yacon treatment showed no
effects on pancreatic β-cells recovery.
Discussion
Ipomoea batatas L. (Caiapo), Agaricus blazei Murill (Agaricus),
and Smallanthus sonchifolius Poepp. & Endl. (Yacon) are known to
favorably influence diabetes mellitus. However, their antidiabetic
efficacy and hypoglycemic mechanisms are not fully determined.
In the present study, we have shown that the treatments of
Ipomoea batatas and Agaricus blazei suppress the increase in
oxidative stress and TNF-α production in STZ-induced diabetes,
and are useful in pancreatic β-cells recovery.
There has been much recent attention given to the relationship
between diabetes and oxidative stress. Excessive superoxide
production is likely to injury pancreatic β-cells and to weaken
the insulin production. In this study, superoxide production by
peripheral blood monocytes and neutrophils was increased in
diabetic rats, accompanied by an increase in the levels of serum
8-OHdG, which displays cellular DNA damage as described in
the text. We also demonstrated that the levels of plasma glucose
and HbA1c were correlated with increased oxidative stress in
diabetic rats. These findings are coincident with the reports that
superoxide production and 8-OHdG levels from peripheral blood
Fig. 5. (a) Lucigenin enhanced chemiluminescence intensity in aortas
after the treatments with Ipomoea batatas (Caiapo), Agaricus blazei
(Agarics) or Smallanthus sonchifolius (Yacon). Chemiluminescence in the
vascular homogenates 8 weeks after the treatments was measured by
lucigenin enhanced chemiluminescence using luminometer analyzer.
Values were shown as counts/10 min/30 mg wet tissue weight. Super 
oxide production was increased in diabetic rats. Treatment with Caiapo
significantly suppressed the oxidative stress in aorta. Values are
mean ± SEM (n = 4–5). #p<0.05 vs normal control, *p<0.05 vs untreated
diabetic control. NC; normal control, D + None; untreated diabetic
control, D + Caiapo; Ipomoea batatas treated diabetic group,
D + Agarics;  Agaricus blazei treated diabetic group, D + Yacon;
Smallanthus sonchifolius treated diabetic group.
(b) Nitrotyrosine formation in aortas after the treatments with Ipomoea
batatas (Caiapo), Agaricus blazei (Agarics) or Smallanthus sonchifolius
(Yacon). The values were measured by western blotting in the vascular
homogenates 8 weeks after the treatments. Data are expressed as
the relative ratio to normal control, which were assigned as value of 1.
Nitrotyrosine formation was significantly increased in diabetic rats.
Treatment with Caiapo significantly suppressed the oxidative stress in
aorta. Values are mean ± SEM (n =5 ) .   #p<0.05 vs normal control,
*p<0.05 vs untreated diabetic control. NC; normal control, D + None;
untreated diabetic control, D + Caiapo; Ipomoea batatas treated
diabetic group, D + Agarics; Agaricus blazei treated diabetic group,
D+Y a c o n ;   Smallanthus sonchifolius treated diabetic group.
Fig. 6. Urinary TNF α excretion after 5 weeks (filled bar) and 7 weeks
(striped bar) of treatments with Ipomoea batatas (Caiapo), Agaricus
blazei (Agarics) or Smallanthus sonchifolius (Yacon). TNF α levels were
measured in the urine of 5 and 7 weeks after the treatments using
enzyme linked immunosorbent assay. Urinary TNF α excretion was
markedly increased in untreated diabetic rats. Caiapo and Agaricus
significantly reduced urinary TNF α excretion after 5 weeks with treat 
ments. Values are mean ± SEM (n =5 ) .  ##p<0.01 vs normal control,
*p<0.05 vs untreated diabetic control. NC; normal control, D + None;
untreated diabetic control, D + Caiapo; Ipomoea batatas treated
diabetic group, D + Agarics; Agaricus blazei treated diabetic group,
D+Y a c o n ;   Smallanthus sonchifolius treated diabetic group. J. Clin. Biochem. Nutr. | May 2011 | vol. 48 | no. 3 | 199
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monocytes were significantly higher in diabetic patients than in
healthy people,(46) and that there was a correlation between the
rise of HbA1c and oxidative stress levels from peripheral blood
monocytes in diabetic patients.(47) Here, it is of note that long-term
treatments with Ipomoea batatas or Agaricus blazei significantly
suppressed the increase in HbA1c and oxidative stress in diabetes
animals (Figs. 1 and 3).
Furthermore, Sheetz and King(48) and Aslan et al.(49) have
reported that free radicals induced oxidative stress-related gene
expressions and peroxidization of plasma membrane, and that
contributed to the development of various diabetic complications.
Consistently, the present study showed that oxidative stress levels
in the aortas of diabetic rats were markedly increased, as shown in
the results in superoxide production (Fig. 5a) and nitrotyrosine
Fig. 7. Activation of p38 mitogen activated protein kinase (MAP
kinase) in aortas after the treatments with Ipomoea batatas (Caiapo),
Agaricus blazei (Agarics) or Smallanthus sonchifolius (Yacon). The
values were measured by western blotting in the vascular homogenates
8 weeks after the treatments. (a) shows a typical western blot analysis
of vascular homogenates, using p38 MAP kinase antibody (upper) and
phopho p38 MAP kinase antibody (Thr180/Thr182) (lower). P38 expres 
sion (b) and its phosphorylation (c) were significantly increased in
diabetic rats. Treatment with Caiapo significantly suppressed p38 MAP
kinase activation in aorta. Data are expressed as the relative ratio to
normal control, which were assigned as value of 1. Values are
mean ± SEM (n =5 ) .  #p<0.05 vs normal control, *p<0.05 vs untreated
diabetic control. NC; normal control, D + None; untreated diabetic
control, D + Caiapo; Ipomoea batatas treated diabetic group,
D + Agarics;  Agaricus blazei treated diabetic group, D + Yacon;
Smallanthus sonchifolius treated diabetic group.
Fig. 8. Typical pancreatic islets in (a) normal control, (b) untreated
diabetic control (DC), and (c) Agaricus blazei (Agarics) treated diabetic
rats. Pancreatic β cells showed blue or purple by aldehyde fuchsin
staining. Following STZ injection, remarkable degranulation of
pancreatic  β cells was observed. The remaining β cells of DC or
Smallanthus sonchifolius (Yacon) treated diabetic rats were inter 
spersed between the pancreatic cells and exhibited little to no cyto 
plasmic staining. Treatments with Agaricus blazei (Agarics) or Ipomoea
batatas (Caiapo) tended to increase β cells mass in STZ induced diabetic
rats. Scale bar; 200 μm.doi: 10.3164/jcbn.10 78
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formation (Fig. 5b). Nitrotyrosine is a footprint of increased
peroxynitrite presence, which is the reactive product of superoxide
and nitric oxide, and is a highly reactive radical species. Lakey
et al.(50) have reported that peroxynitrite is a mediator of cytokine-
induced destruction of human pancreatic islet β-cells. Of profound
importance, treatments with Ipomoea batatas or Agaricus blazei
significantly reduced the production of reactive oxygen species in
vascular cells as well as peripheral blood cells.
Recent study shows the evidence for evaluation of nitrotyrosine
and TNF-α as potential biomarkers of the presence, severity
and progress of diabetes and its complication.(51) TNF-α, a proin-
flammatory cytokine, is mainly secreted from monocytes and
macrophages, and also produced in various other tissues. It has
reported that TNF-α affects not only peripheral insulin resis-
tance,(52) but also directly pancreatic β-cells, followed by their
apoptosis and reduction of insulin secretion.(53) It has also
demonstrated that high glucose participate in the production of
inflammatory cytokines including TNF-α through the activation
of nuclear transcription factor.(54)
Here we shows that TNF-α production remarkably increased in
STZ-induced diabetic rats and that treatments of Ipomoea batatas
or Agaricus blazei had significant suppressive effect on urinary
TNF-α level (Fig. 6). Additionally, Ipomoea batatas depressed
p38 MAP kinase expression and activation (Fig. 7). P38 MAP
kinase is potently and preferentially activated by a variety of
stress including oxidative stress and inflammatory cytokines
and receptor systems of the TNF family.(45) Excretion of urinary
albumin was also significantly increased in diabetic rats and
suppressed after 5 weeks of treatments with Ipomoea batatas,
Agaricus blazei, and Smallanthus sonchifolius. It supports our
result that increase in urinary TNF-α level is associated with the
onset of diabetic nephropathy.(40)
Ipomoea batatas-treated and Agaricus blazei-treated rats
exhibited the recovery tendency on serum insulin levels along the
treatments (Fig. 4). In the histochemical examination of pancreatic
islets (Table 1, Fig. 8), a recovery tendency of islet β-cells mass
was also observed in Ipomoea batatas or Agaricus blazei groups.
These results suggest that there is a possibility that Ipomoea
batatas or Agaricus blazei has a protective effect on islet cell
destruction and increases the secretion of insulin. On the other
hand, Kusano and Abe(10) have reported that Ipomoea batatas
extract directly secretes insulin and improves insulin resistance.
Gray and Flatt(19) have found the insulin-like activity and the
insulin-releasing effect of Agaricus blazei, although the nature or
the mechanisms of action was not determined.
Taken together, hypoglycemic effects of Ipomoea batatas or
Agaricus blazei are likely to be their antioxidant and anti-
inflammatory action. The leaves and roots of Ipomoea batatas
used in this study have abundant phenolic compounds, such as
chlorogenic acid, caffeic acid, and its derivatives,(11) which
exhibit high radical-scavenging activity, antimutagenic, and
antidiabetic effects.(55,56) Ipomoea batatas is rich in ascorbic acid,
a well-known antioxidant molecule. The plant also contains
large amounts of dietary fibers, which may interfere with glucose
absorption and further reduce blood glucose levels.
On the other hand, the fruit body of Agaricus blazei has highly
branched 1,3-glucan as the major carbohydrate component.(57) β-
glucan is a well-known biological response modifier which is
widely distribution in nature and used as an alternative medicine.
Although the previous reports concerning the oxidative/anti-
oxidative activity of β-glucan are controversial, β-glucan treat-
ment was found to be effective against oxidative injury through
the inhibition of TNF-α response.(58–60) In addition, Agaricus blazei
contains polyphenol oxidase, an antioxidant enzyme.(28,29) Cupper,
zinc, and selenium contained richly in Ipomoea batatas and
Agaricus blazei may be beneficial for the protection against
radical generation, because the minerals have radical-scavenging
activities and are contained in antioxidant enzymes. It is important
that neither significant adverse effects nor biochemical changes of
blood were observed in our other experiment using Ipomoea
batatas, Agaricus blazei, or Smallanthus sonchifolius.
In opposition to previous reports,(21,22) Smallanthus sonchifolius
did not improve in glucose balance, oxidative stress or inflam-
matory response. We used primarily dried tuber and stem powder
of  Smallanthus sonchifolius in this study, and there may be a
possibility of discrepancy between our results and the results of
other reports which utilized the decoction from the leaves.
Collectively, we provide that cellular oxidative is a critical
step in STZ-mediated islet β-cells injury, and that Ipomoea batatas
and Agaricus blazei protect the organs from oxidative damage
by those immunomodulatory (inhibition of TNF-α formation and
its signaling pathway) and antioxidant properties. Excessive NO
production is recently thought to be involved in the pathogenesis
of metabolic disorders such as atherosclerosis and obesity-linked
type 2 diabetes.(61,62) Proinflammatory cytokines including TNF-α
increase nitric oxide (NO) production through the expression of
inducible NO synthase in adipocytes and in skeletal muscle of
obese human subjects and several diabetic animal models.(62,63) In
the present study using STZ-induced diabetic rats, rise of plasma
or urine NOx levels was not detected. However, we do not exclude
the possible mechanism, because nitrotyrosine formation was
markedly increased in vascular cells of untreated diabetic rats
(Fig. 5b).
In conclusion, treatments with Ipomoea batatas or Agaricus
blazei suppressed the increases of blood glucose and HbA1c levels
in streptozotocin-induced type 2 diabetes model rats, and restored
insulin release and their body weight loss. The results suggest
that the antidiabetic effects result from the suppression of oxida-
tive stress and proinflammatory cytokine, TNF-α, and improve-
ment in β-cells mass. Further precise mechanism of suppression
on oxidative stress and/or TNF-α production by the components
of Ipomoea batatas or Agaricus blazei remains to be elucidated.
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